Engineering Nanocarriers for siRNA Delivery

The discovery of RNA interference has revitalized the long ongoing pursuit of gene therapy for the treatment of diseases. Nevertheless, despite promising results from experimental studies, there remains a pressing need for the development of nanocarriers that are clinically‐relevant, biocompatible,...

Full description

Saved in:
Bibliographic Details
Published inSmall (Weinheim an der Bergstrasse, Germany) Vol. 7; no. 7; pp. 841 - 856
Main Authors Tan, Shawn J., Kiatwuthinon, Pichamon, Roh, Young Hoon, Kahn, Jason S., Luo, Dan
Format Journal Article
LanguageEnglish
Published Weinheim WILEY-VCH Verlag 04.04.2011
WILEY‐VCH Verlag
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The discovery of RNA interference has revitalized the long ongoing pursuit of gene therapy for the treatment of diseases. Nevertheless, despite promising results from experimental studies, there remains a pressing need for the development of nanocarriers that are clinically‐relevant, biocompatible, efficient, and that can be tailored to specific disease targets. This review surveys the broad spectrum of nanomaterials and their functional add‐ons, and aims to provide a guide towards engineering nanocarriers for effective siRNA delivery. Nanomaterials for drug delivery: There is a pressing need for the development of nanocarriers that are clinically‐relevant, biocompatible, efficient, and that can be tailored to specific disease targets. This review surveys the broad spectrum of nanomaterials and their functional add‐ons, and aims to provide a guide towards engineering nanocarriers for effective siRNA delivery.
Bibliography:istex:BB973F64944C1DB209E6A34A6DB335FB30628041
ArticleID:SMLL201001389
ark:/67375/WNG-GSJQ9FR4-0
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-2
ObjectType-Feature-2
ISSN:1613-6810
1613-6829
1613-6829
DOI:10.1002/smll.201001389